Journal Articles Citing Cryopreservation Component Recently Added to BioLife Solutions’ Evidence Library

Cryopreservation adds flexibility to timelines when working with cells. In the case of cellular therapies, that can mean initial flexibility to schedule patient cell collection, transport cells to the manufacturing facility and initiate manufacturing. Cryopreservation of the final cell therapy product adds flexibility to be able to schedule the return of cells to the patient…

Read More

c-Jun overexpression in CAR T cells induces exhaustion resistance

Lynn, R. C., Weber, E. W., Sotillo, E., Gennert, D., Xu, P., Good, Z., Anbunathan, H., Lattin, J., Jones, R., Tieu, V., Nagaraja, S., Granja, J., de Bourcy, C. F. A., Majzner, R., Satpathy, A. T., Quake, S. R., Monje, M., Chang, H. Y. and Mackall, C. L.  c-Jun overexpression in CAR T cells induces…

Read More

Our New White Paper on The Importance of Collection, Processing and Biopreservation Best Practices in Determining CAR-T Starting Material Quality

BioLife recently partnered with HemaCare and BioInsights to create our latest Biopreservation Best Practices White Paper. See for yourself how critical starting material quality is for CAR-T and other cell manufacturing and learn how to best optimize your biopreservation methods to follow best practices.    

Read More